JP2022535178A5 - - Google Patents
Info
- Publication number
- JP2022535178A5 JP2022535178A5 JP2021544344A JP2021544344A JP2022535178A5 JP 2022535178 A5 JP2022535178 A5 JP 2022535178A5 JP 2021544344 A JP2021544344 A JP 2021544344A JP 2021544344 A JP2021544344 A JP 2021544344A JP 2022535178 A5 JP2022535178 A5 JP 2022535178A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024202674A JP2025037913A (ja) | 2019-01-30 | 2024-11-20 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798908P | 2019-01-30 | 2019-01-30 | |
| PCT/US2020/015982 WO2020160342A1 (en) | 2019-01-30 | 2020-01-30 | Methods and compositions for developing target specific exosome and growth factor products |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024202674A Division JP2025037913A (ja) | 2019-01-30 | 2024-11-20 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022535178A JP2022535178A (ja) | 2022-08-05 |
| JPWO2020160342A5 JPWO2020160342A5 (https=) | 2023-02-07 |
| JP2022535178A5 true JP2022535178A5 (https=) | 2023-02-07 |
Family
ID=71842346
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544344A Pending JP2022535178A (ja) | 2019-01-30 | 2020-01-30 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
| JP2024202674A Pending JP2025037913A (ja) | 2019-01-30 | 2024-11-20 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024202674A Pending JP2025037913A (ja) | 2019-01-30 | 2024-11-20 | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220136053A1 (https=) |
| EP (1) | EP3917489A4 (https=) |
| JP (2) | JP2022535178A (https=) |
| KR (1) | KR20210121183A (https=) |
| AU (1) | AU2020214832A1 (https=) |
| BR (1) | BR112021014994A2 (https=) |
| CA (1) | CA3128050A1 (https=) |
| IL (1) | IL285228A (https=) |
| JO (1) | JOP20210202A1 (https=) |
| MX (1) | MX2021009254A (https=) |
| SG (1) | SG11202108129SA (https=) |
| WO (1) | WO2020160342A1 (https=) |
| ZA (1) | ZA202105483B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021526556A (ja) | 2018-05-30 | 2021-10-07 | ダイレクト バイオロジクス エルエルシー | 成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞（ｍｓｃ）の調製物を含む助剤、ならびにその使用方法 |
| BR112021015549A2 (pt) | 2019-02-07 | 2021-10-26 | Direct Biologics Llc | Método para tratar osteoartrite com uma combinação de exossomos de células tronco mesenquimais, células tronco mesenquimais sinoviais e andaimes |
| CA3146433A1 (en) | 2019-07-18 | 2021-01-21 | Direct Biologics Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
| US12590310B2 (en) | 2020-04-22 | 2026-03-31 | Direct Biologics, Llc | Methods and compositions for treating inflammatory conditions associated with infectious disease |
| JP2023180556A (ja) * | 2022-06-09 | 2023-12-21 | 日本メナード化粧品株式会社 | 薄毛の遺伝的素因の判定方法 |
| WO2024233684A2 (en) * | 2023-05-08 | 2024-11-14 | Vitti Labs | Methods of treating ovarian conditions and diseases |
| US12502407B2 (en) | 2024-04-25 | 2025-12-23 | Direct Biologics, Llc | Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles |
| CN118516305B (zh) * | 2024-07-22 | 2024-11-26 | 深圳大学 | 力学信号调控下的外泌体制备方法、外泌体及其在骨、软骨再生修复领域的应用 |
| CN120899659A (zh) * | 2025-08-06 | 2025-11-07 | 河北医科大学第三医院 | 一种过表达cap基因和lgr5基因的外泌体在制备治疗软骨炎症药物中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090177487A1 (en) * | 2008-01-07 | 2009-07-09 | Tera Eerkes | Methods for Assessing Genetic Compatibility |
| CN102014934B (zh) * | 2008-02-22 | 2014-08-20 | 新加坡科技研究局 | 间充质干细胞颗粒 |
| ES2746554T3 (es) * | 2010-11-02 | 2020-03-06 | Univ Columbia | Métodos para tratar los trastornos de pérdida de cabello |
| US20130129688A1 (en) * | 2011-11-09 | 2013-05-23 | Allocure, Inc. | Assay for the Prediction of Therapeutic Effectiveness or Potency of Mesenchymal Stem Cells, and Methods of Using Same |
| CA2866563A1 (en) * | 2012-03-07 | 2013-09-12 | Fibrocell Technologies, Inc. | Topical dermal formulations and methods of personalized treatment of skin |
| EP3270984A4 (en) * | 2015-03-16 | 2019-04-17 | Duncan Ross | TREATMENT METHOD WITH MEMBRANE-INCLUDED VESICLE |
| AU2016261358B2 (en) * | 2015-05-11 | 2021-09-16 | Editas Medicine, Inc. | Optimized CRISPR/Cas9 systems and methods for gene editing in stem cells |
| MX2019005127A (es) * | 2016-11-03 | 2019-09-26 | Exostem Biotec Ltd | Poblaciones y productos de células madre mesenquimales y sus usos. |
| US10987381B2 (en) * | 2017-01-27 | 2021-04-27 | Neil Riordan | Mesenchymal stem cells with enhanced efficacy in treatment of autoimmunity particularly rheumatoid arthritis |
| WO2018162696A1 (en) * | 2017-03-10 | 2018-09-13 | Institut Pasteur | Common genetic variations at the tcra-tcrd locus control thymic function in humans |
| JP2021526556A (ja) * | 2018-05-30 | 2021-10-07 | ダイレクト バイオロジクス エルエルシー | 成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞（ｍｓｃ）の調製物を含む助剤、ならびにその使用方法 |
| KR20210121039A (ko) * | 2018-12-26 | 2021-10-07 | 다이렉트 바이오로직스 엘엘씨 | 피부 및 모발 장애를 치료하기 위한 방법 및 조성물 |
-
2020
- 2020-01-30 AU AU2020214832A patent/AU2020214832A1/en not_active Abandoned
- 2020-01-30 SG SG11202108129SA patent/SG11202108129SA/en unknown
- 2020-01-30 WO PCT/US2020/015982 patent/WO2020160342A1/en not_active Ceased
- 2020-01-30 CA CA3128050A patent/CA3128050A1/en active Pending
- 2020-01-30 JP JP2021544344A patent/JP2022535178A/ja active Pending
- 2020-01-30 BR BR112021014994-5A patent/BR112021014994A2/pt not_active Application Discontinuation
- 2020-01-30 KR KR1020217027591A patent/KR20210121183A/ko not_active Withdrawn
- 2020-01-30 JO JOP/2021/0202A patent/JOP20210202A1/ar unknown
- 2020-01-30 MX MX2021009254A patent/MX2021009254A/es unknown
- 2020-01-30 EP EP20748749.7A patent/EP3917489A4/en active Pending
- 2020-01-30 US US17/427,192 patent/US20220136053A1/en active Pending
-
2021
- 2021-07-29 IL IL285228A patent/IL285228A/en unknown
- 2021-08-02 ZA ZA2021/05483A patent/ZA202105483B/en unknown
-
2024
- 2024-11-20 JP JP2024202674A patent/JP2025037913A/ja active Pending